Longer dupilumab dosing intervals in adult patients with atopic dermatitis: experience from a French multicentre retrospective cohort study.
作者信息
Jendoubi Fatma, Shourik Jason, Seneschal Julien, Giordano-Labadie Francoise, Raison-Peyron Nadia, Du-Thanh Aurélie, Tetart Florence, Valois Aude, Droitcourt Catherine, Clément Aude, Nosbaum Audrey, Crepy Marie Noelle, Jachiet Marie, Bouaziz Jean David, Bernier Claire, Soria Angéle, Paul Carle, Barbarot Sebastien, Tauber Marie
机构信息
Dermatology Department, Toulouse University and CHU (University Hospital), Toulouse, France.
出版信息
Br J Dermatol. 2022 Oct;187(4):602-603. doi: 10.1111/bjd.21628. Epub 2022 Jul 11.
Abstract
摘要
相似文献
1
Longer dupilumab dosing intervals in adult patients with atopic dermatitis: experience from a French multicentre retrospective cohort study.成人特应性皮炎患者使用度普利尤单抗的更长给药间隔：一项法国多中心回顾性队列研究的经验
Br J Dermatol. 2022 Oct;187(4):602-603. doi: 10.1111/bjd.21628. Epub 2022 Jul 11.
2
Use of dupilumab in pediatric atopic dermatitis: Access, dosing, and implications for managing severe atopic dermatitis.度普利尤单抗在儿童特应性皮炎中的应用：可及性、给药方案及对重度特应性皮炎管理的意义
Pediatr Dermatol. 2019 Jan;36(1):172-176. doi: 10.1111/pde.13707.
3
[Translated article] RF-Longer Dupilumab Dosing Intervals in Atopic Dermatitis: Optimization or Therapeutic Failure?[翻译文章] 特应性皮炎中更长的度普利尤单抗给药间隔：是优化还是治疗失败？
Actas Dermosifiliogr. 2024 Sep;115(8):T825-T827. doi: 10.1016/j.ad.2024.07.008. Epub 2024 Jul 5.
4
Real-world experience of dupilumab treatment for atopic dermatitis in adults: a retrospective analysis of patients' records.真实世界中成人特应性皮炎患者接受度普利尤单抗治疗的经验：患者病历的回顾性分析。
Int J Dermatol. 2020 Feb;59(2):253-256. doi: 10.1111/ijd.14573. Epub 2019 Jul 8.
5
Use of Dupilumab for Adult-Onset Atopic Dermatitis: A Real-World Retrospective Study.度普利尤单抗用于成人发作性特应性皮炎：一项真实世界回顾性研究。
J Cutan Med Surg. 2024 Jan-Feb;28(1):96-97. doi: 10.1177/12034754231220933. Epub 2023 Dec 29.
6
Extending dupilumab dosing intervals in atopic dermatitis: A prospective observational study in a South European tertiary hospital.延长度普利尤单抗在特应性皮炎中的给药间隔：一项在南欧三级医院进行的前瞻性观察研究。
J Eur Acad Dermatol Venereol. 2024 Feb;38(2):e193-e194. doi: 10.1111/jdv.19528. Epub 2023 Sep 25.
7
Off-label use of dupilumab for pediatric patients with atopic dermatitis: A multicenter retrospective review.地氯雷他定在特应性皮炎患儿中的超适应证使用：一项多中心回顾性研究。
J Am Acad Dermatol. 2020 Feb;82(2):407-411. doi: 10.1016/j.jaad.2019.10.010. Epub 2019 Oct 10.
8
Efficacy of Dupilumab for Atopic Dermatitis According to Clinical Course and Clinical Findings: A Multicentre Retrospective Study.根据临床病程和临床表现评估度普利尤单抗治疗特应性皮炎的疗效：一项多中心回顾性研究
Acta Derm Venereol. 2021 Nov 10;101(11):adv00586. doi: 10.2340/actadv.v101.369.
9
Dupilumab for the Treatment of Atopic Dermatitis.度普利尤单抗治疗特应性皮炎
Actas Dermosifiliogr (Engl Ed). 2018 Apr;109(3):230-240. doi: 10.1016/j.ad.2017.10.012. Epub 2018 Feb 13.
10
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis.成人中重度特应性皮炎患者使用度普利尤单抗的有效性和安全性的真实世界经验。
J Dermatolog Treat. 2021 Aug;32(5):507-513. doi: 10.1080/09546634.2019.1682503. Epub 2019 Oct 28.
引用本文的文献
1
Onset and Long-Term Maintenance of Optimal Itch Response in Adult Patients with Moderate-to-Severe Atopic Dermatitis Treated with Dupilumab: Post Hoc Analysis from Two Phase 3 Trials.使用度普利尤单抗治疗的中度至重度特应性皮炎成年患者最佳瘙痒反应的起效和长期维持：两项3期试验的事后分析
Adv Ther. 2025 Apr;42(4):1800-1810. doi: 10.1007/s12325-025-03124-8. Epub 2025 Feb 19.
2
Upadacitinib Dose Reduction Regimen in Elderly Patients with Atopic Dermatitis, Guided by Treat-to-Target Consensus Recommendations.根据治疗目标共识建议指导的老年特应性皮炎患者的乌帕替尼减量方案
Am J Clin Dermatol. 2025 May;26(3):437-447. doi: 10.1007/s40257-025-00923-1. Epub 2025 Feb 12.
3
Appropriate Injection Intervals of Dupilumab in Patients With Adult Atopic Dermatitis: A Step Toward Developing Guidelines for Daily Practice.度普利尤单抗在成人特应性皮炎患者中的合适注射间隔：迈向制定日常实践指南的一步。
Ann Dermatol. 2025 Feb;37(1):39-45. doi: 10.5021/ad.24.084.
4
Systemic Therapy for Atopic Dermatitis in Children and Adolescents: A US Expert Consensus.儿童和青少年特应性皮炎的全身治疗：美国专家共识
Dermatology. 2024;240(5-6):897-909. doi: 10.1159/000540920. Epub 2024 Oct 15.
5
Perception and Experience of Dupilumab in Atopic Dermatitis: A Real-Life Study.度普利尤单抗治疗特应性皮炎的认知与体验：一项真实世界研究
Patient Prefer Adherence. 2023 Sep 15;17:2289-2293. doi: 10.2147/PPA.S419655. eCollection 2023.
本文引用的文献
1
Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis: A Randomized Clinical Trial.多种度普利尤单抗剂量方案在特应性皮炎初始成功治疗后的疗效和安全性：一项随机临床试验。
JAMA Dermatol. 2020 Feb 1;156(2):131-143. doi: 10.1001/jamadermatol.2019.3617.
Zotero 插件